TLDR
- Tether plans to invest over $1 billion through its venture capital arm Tether Investments within the next 12 months.
- The main areas of focus for these investments are alternative financial infrastructure for emerging markets, artificial intelligence (AI), and biotechnology.
- Tether has already invested around $2 billion in these sectors over the past two years, including $18.75 million in XREX Group for cross-border payments and $200 million to become a majority stakeholder in biotech firm Blackrock Neurotech.
- Tether aims to expand its distribution network, drive innovation, and reduce reliance on major tech companies through these investments, aligning with its recent restructuring into four business divisions.
- While allocating over $1 billion for new investments, Tether still plans to maintain 100% reserves plus a 6% cushion to ensure USDT stablecoin redemptions remain fully backed.
Tether, the company behind the world’s largest stablecoin USDT, has unveiled ambitious investment plans that demonstrate its growing financial power and influence beyond just issuing its dollar-pegged cryptocurrency.
In a recent interview, Tether’s CEO Paolo Ardoino stated that the firm intends to allocate over $1 billion to various investment opportunities over the next 12 months through its venture capital arm, Tether Investments.
A significant portion of this substantial investment will be directed towards emerging sectors that align with Tether’s strategic vision. These include alternative financial infrastructure for emerging markets, artificial intelligence (AI), and biotechnology.
Ardoino emphasized that the investments aim to leverage technologies that facilitate disintermediation from traditional finance while reducing reliance on major tech giants like Google, Amazon, and Microsoft.
This bold investment strategy builds upon Tether’s existing forays into these domains. Over the past two years alone, the company has already invested approximately $2 billion across these sectors.
Some notable recent investments include an $18.75 million commitment to XREX Group, a regulated blockchain-enabled financial institution based in Taiwan.
This investment is intended to enhance cross-border payments, foster financial inclusion in emerging markets, and drive the development of regulatory technology to combat the illicit use of stablecoins.
Tether has made a significant $200 million investment in Blackrock Neurotech, a leading biotech company specializing in brain-computer interface (BCI) technology.
This strategic move establishes Tether as the majority stakeholder in Blackrock Neurotech, with the goal of advancing medical solutions for individuals with paralysis, neurological disorders, and lost function.
Beyond these specific investments, Tether has also allocated over $1 billion towards initiatives in the field of artificial intelligence, including support for data center operator Northern Data Group.
Ardoino explained that Tether’s approach to investing differs from traditional venture capitalists, as the company focuses on projects it finds “exceptionally compelling” and aligned with its long-term strategic vision, rather than solely prioritizing short-term profitability targets.
